Latest Kaiser Health News Stories
The president’s doctors have used HIPAA — the Health Insurance Portability and Accountability Act — as a shield to avoid questions about the president’s COVID-19 diagnosis.
Paid even less than low-wage doctors’ scribes in the United States, remote note takers in India gain a foothold in a rapidly expanding industry.
Big data plays a critical role in the success of current public health efforts to control the spread of the coronavirus. Privacy advocates, though, are watching closely.
It’s November, do you know where your HHS spending bill is? Still stuck in Congress. Meanwhile, lawmakers move ahead on restricting tobacco products for youth while the administration’s proposal is MIA. Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more health news from the week. Also, Rovner interviews Dan Weissmann, host of the podcast “An Arm and a Leg.”
Se llaman a sí mismas muñecas. Son pacientes de cirugía estética que documentan sus deseos y resultados en Instagram. Una comunidad cerrada con mensajes médicos, pero también marketing.
An Instagram community of “doll pages” lets women find valuable information about body-sculpting journeys.
Capitalizing on the growing popularity of genetic testing — and fears of terminal illness — scammers are persuading seniors to hand over cheek swabs with their DNA, not knowing it may lead to identity theft and Medicare fraud.
Amazon se ha asociado con numerosas compañías de atención médica, incluyendo varias en California, para permitir que los clientes y empleados usen Alexa para ayudarlos con la atención médica.
Amazon, along with a host of other technology companies, is working on ways to use its smart speaker devices to bring a range of health care services into your home.
El objetivo de la recopilación de datos, según Sleep Number y otras compañías, es ayudar a los estadounidenses a dormir mejor. Qué opinan los defensores de los consumidores.
An array of products — from mattresses and sensors to sleep trackers and apps — are catching consumers’ attention. But privacy experts are concerned about what becomes of all the personal information these products collect.
For the seventh year in a row, Missouri will retain its lonely title as the only state without a statewide prescription drug monitoring program. Fears about privacy violations and gun control scuttled the bill yet again, leaving a pastiche of half-step measures in place to fill the void in the fight against prescription drug abuse.
Federal law bars insurers from using these test results for health coverage, but they can influence whether you get a plan covering long-term care.
Las compañías de recopilación de datos pueden espiar tus hábitos de consumo y vender esa información a farmacéuticas y aseguradoras.
Consumers, beware: Data brokers compile health and frailty profiles that have wide-ranging applications for drug companies, advertisers, insurers and other buyers.
Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Talking Points Memo discuss the latest on states’ efforts to reshape their Medicaid programs, the kerfuffle over President Donald Trump’s medical records and comments by former Health and Human Services Secretary Tom Price about Congress’ repeal of the Affordable Care Act’s “individual mandate” penalty. Rovner also interviews Harvard professor Robert Blendon about the complex politics of health in the coming midterm elections.
A lawsuit claims that a private company hired by the state public health department to manage enrollment in an AIDS drug assistance program for low-income patients inadvertently allowed unauthorized access to their medical status.
In a low-tech snafu, information about HIV treatment was visible through the cellophane window on envelopes sent to about 12,000 consumers.
La aseguradora envío cartas en las que era visible la parte en la que se mencionaba que los destinatarios estaban tomando medicamentos contra el VIH.